Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.
Humacyte stock last closed at $1.68, up 8.39% from the previous day, and has decreased 46.15% in one year. It has overperformed other stocks in the Biotechnology industry by 0.32 percentage points. Humacyte stock is currently +46.09% from its 52-week low of $1.15, and -83.15% from its 52-week high of $9.97.
There are currently 155.12M shares of HUMA outstanding. The market cap of HUMA is $260.60M. In the past 24 hours, 3.09M HUMA shares were traded.
How to Buy Humacyte Stock
Not sure how to invest in Humacyte stock? Here's how.
Decide where to buy Humacyte stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Humacyte stock.
Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit funds into your investment account: Pick your method of payment and add your information.
Research Humacyte stock: The Humacyte ticker symbol is HUMA. Is Humacyte stock a good investment? Should you buy shares of HUMA? How do HUMA's underlying business fundamentals look? Do top analysts think Humacyte is a good buy? Why has HUMA's stock price moved recently? (Hint: Our stock market research website can help you figure out if HUMA is a good stock to buy).
Make your HUMA trade: Decide if you will purchase HUMA shares at the current market price or use a limit order to purchase HUMA shares at a given price.
Get key alerts regarding your investment in HUMA: Create a watchlist to keep tabs on your new investment in Humacyte stock.
Step 1: Decide where to buy Humacyte stock
You need a brokerage account in order to access the NASDAQ market and buy HUMA shares.
A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global financial markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal details so you can buy HUMA today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Humacyte stock
Once you have decided on the best place to buy Humacyte stock, it's important to analyze their stock prior to buying, so you actually understand the risk and opportunity.
Humacyte Metrics
HUMA Price
$1.68
1w %
7.01%
1y %
-46.15%
5y %
N/A
P/E
-1.33x
P/B
-4.95x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$148.70M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$260.60M
Next Earnings
May 8, 2025
Next Dividend
N/A
Humacyte Due Diligence Score
WallStreetZen was designed to help everyday investors perform better fundamental analysis in minutes instead of hours.
Last year, HUMA revenue was $0.00. During the last 5 year, HUMA's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 44.43%.
In the last 12 months, insiders at HUMA have sold more shares than they have bought.
William John Scheessele, Chief Commercial Officer of HUMA, was the latest HUMA insider to buy. They bought $9,999.22 worth of HUMA stock on Apr 14, 2025.
No, Humacyte doesn't provide an income stream by paying out dividends.
HUMA Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your HUMA trade
You have two main order types:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly fine for most investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at an exact price, place a limit order.
Press the Open Trade button and eToro will execute your order.
If you want additional info about buying stocks on eToro, click the how to video below:
As of Apr 17, 2025, it costs $1.68 to buy one share of Humacyte stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.84, you can buy 0.5 shares of HUMA.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.